Research Article

Comprehensive Analysis of NPSR1-AS1 as a Novel Diagnostic and Prognostic Biomarker Involved in Immune Infiltrates in Lung Adenocarcinoma

Figure 1

The expression of NPSR1-AS1 was distinctly increased in LUAD. (a) 229 DELs (including 216 upregulated lncRNAs and 13 downregulated lncRNAs) between LUAD specimens and nontumor specimens from TCGA datasets were shown in volcano map. (b) Venn diagram showed the overlapping lncRNA between 229 DELs and 382 survival-related lncRNAs. (c) The expression of NPSR1-AS1 in LUAD specimens and nontumor specimens. (d, e) ROC assays were used to investigate the diagnostic value of NPSR1-AS1 for LUAD patients in the datasets obtained from TCGA.